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Identity 
Other names: TRE2; TRE17 
HGNC (Hugo): USP6 
Location: 17p13 
Note 
The gene is the result of a recent evolutionary fusion of 
two other genes - TBC1D3 (PRC17) on chromosome 
17q12 and USP32 (NY-REN-60) on chromosome 
17q22 (see below). 
DNA/RNA 
Description 
30 exons spanning 47 kb of genomic DNA. Exons 1 to 
14 are derived from the TBC1D3 (PRC17), and exons 
15 to 30 are derived from the USP32 (NY-REN-60). 
Transcription 
The gene is transcribed from telomere to centromere. 
The coding region starts on exon 2 but  
many splicing variants have been identified in the 
untranslated exon 1. There are at least two major 
transcripts with an approximate lenght of 8 kb. 
Protein 
Description 
USP6 encodes for a 1406 aminoacid protein containing 
two major domains: TBC (from TRE2-Bub2-Cdc16), 
which encodes a GTPase-activating protein of the Rab 
family of GTPases, and a UBP domain with a ubiquitin 
specific protease activity. A USP6 splicing variant, also 
known as ‘onco-TRE17 or TRE17-onco’, encodes a 
786 aminoacid protein with a truncated UBP domain. 
See figure 1. 
Expression 
Among normal tissues, USP6 seems to primarily 














USP6 function is still poorly understood but recent 
evidence has shown that USP6 is involved in endocytic 
trafficking. USP6 seems to operate in the same 
pathway controlled by Arf6 GTPase, which has been 
linked to mitogenic signaling and invasive behavior. 
Homology 
While the N-terminal portion of USP6 is highly 
homologous to PRC17 (89% identity), the C-terminal 
end is highly homologous to USP32 (97% identity). 
 
Implicated in 
Aneurysmal Bone Cyst or Aneurysmal 
Bone Tumor 
Cytogenetics 
Rearrangements of 17p13 with different partner 
chromosomes. 
Hybrid/Mutated gene 
USP6 fusion genes are formed by juxtaposition of 
USP6 coding sequences to the promoter regions of 
several partner genes, which lead to USP6 
transcriptional upregulation. There is no fusion protein. 
THRAP3 -USP6 in t(1;17)(p34;p13) 
ZNF9 -USP6 in t(3;17)(q21;p13) 
OMD -USP6 in t(9;17)(q22;p13) 
CDH11 -USP6 in t(16;17)(q22;p13) 










Huebner K, Cannizzaro LA, Nakamura T, Hillova J, Mariage-
Samson R, Hecht F, Hill M, Croce CM. A rearranged 
transforming gene, tre, is made up of human sequences 
derived from chromosome regions 5q, 17q and 18q. 
Oncogene. 1988 Oct;3(4):449-55 
Nakamura T, Hillova J, Mariage-Samson R, Hill M. Molecular 
cloning of a novel oncogene generated by DNA recombination 
during transfection. Oncogene Res. 1988 May;2(4):357-70 
Nakamura T, Hillova J, Mariage-Samson R, Onno M, Huebner 
K, Cannizzaro LA, Boghosian-Sell L, Croce CM, Hill M. A novel 
transcriptional unit of the tre oncogene widely expressed in 
human cancer cells. Oncogene. 1992 Apr;7(4):733-41 
Martinu L, Santiago-Walker A, Qi H, Chou MM. Endocytosis of 
epidermal growth factor receptor regulated by Grb2-mediated 
recruitment of the Rab5 GTPase-activating protein RN-tre. J 
Biol Chem. 2002 Dec 27;277(52):50996-1002 
Masuda-Robens JM, Kutney SN, Qi H, Chou MM. The TRE17 
oncogene encodes a component of a novel effector pathway 
for Rho GTPases Cdc42 and Rac1 and stimulates actin 
remodeling. Mol Cell Biol. 2003 Mar;23(6):2151-61 
Paulding CA, Ruvolo M, Haber DA. The Tre2 (USP6) 
oncogene is a hominoid-specific gene. Proc Natl Acad Sci U S 
A. 2003 Mar 4;100(5):2507-11 
Martinu L, Masuda-Robens JM, Robertson SE, Santy LC, 
Casanova JE, Chou MM. The TBC (Tre-2/Bub2/Cdc16) 
domain protein TRE17 regulates plasma membrane-
endosomal trafficking through activation of Arf6. Mol Cell Biol. 
2004 Nov;24(22):9752-62 
Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Dal Cin 
P, Joseph N, Bridge JA, Perez-Atayde AR, Fletcher JA. USP6 
(Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer 
Res. 2004 Mar 15;64(6):1920-3 
Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr 
V, Hsi BL, Gebhardt MC, Rosenberg AE, Fletcher JA. USP6 
and CDH11 oncogenes identify the neoplastic cell in primary 
aneurysmal bone cysts and are absent in so-called secondary 
aneurysmal bone cysts. Am J Pathol. 2004 Nov;165(5):1773-
80 
Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen 
CJ, Neff JR, Demetri GD, Rosenberg AE, Bridge JA, Fletcher 
JA. Aneurysmal bone cyst variant translocations upregulate 
USP6 transcription by promoter swapping with the ZNF9, 
COL1A1, TRAP150, and OMD genes. Oncogene. 2005 May 
12;24(21):3419-26 
This article should be referenced as such: 
Oliveira AM, Chou M. USP6 (ubiquitin specific protease 6 (Tre-
2 oncogene)). Atlas Genet Cytogenet Oncol Haematol. 2005; 
9(3):221-222. 
